Shanghai Wibson Biotechnology (revision 20)
Old revision·16:40, 10 Sep 2025·PortalPolly
| Shanghai Wibson Biotechnology Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Shanghai Wibson Biotechnology Co., Ltd. |
| Trading name | SWB |
| Other designations | SWB Biotech, Shanghai Wibson Biotechnology |
| Identity | |
| Founded | 2019 |
| Headquarters | Shanghai, China |
| Industry | Research-compound supply |
| Official site | Visit SWB at shanghaiwibsonbiotechnology.net |
| Products and documentation | |
| Product scope | peptides, SARMs, injectable oils and raw materials |
| Catalogue size | 350+ listings (self-reported) |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| PeptidePedia reception tally | |
| Submissions | 915 to July 2026 |
| Evidence quality | Weak — self-selected, self-reported |
| Organisation infobox · conventions | |
Shanghai Wibson Biotechnology Co., Ltd. (trading as SWB; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Incorporated in 2019, the organisation is among the more recently established covered on this wiki.[1] A shorter registry history is a fact about the record rather than about the operation; it means that observations here rest on reports gathered over a smaller number of years than for the older entities, and the article says so wherever it draws one.
Its registered name places it in biotechnology, which is closer to its trading activity than several comparable registrations.[1] The documentary base for the article is the registry record, the organisation's own published material and purchaser-submitted reports; the notability discussion on the talk page reviewed that base in February 2025 and closed in favour of a standalone article.[1][2][5]
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe conventional practice: lyophilised material in crimped glass vials, batch certificate enclosed, cold pack for the temperature-sensitive lines.[5] Certificates in the submitted set report an area percent purity and an appearance line as standard; the peptide content and water determinations that turn that figure into a net mass are issued against a named lot on request, and §Ordering and availability sets out what to quote when asking.[6]
No certification claim by the organisation has been corroborated by this wiki, and its own statements about capability are self-published.[2]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide | Certificate with purity and appearance; water on request |
| Research peptides | Repair and secretagogue peptides | Certificate with purity; water and method on request |
| SARMs | Bulk and capsuled | Certificate with purity; specification sheet on request |
| Injectable oils and raw materials | Bulk | Certificate with identity and purity; specification sheet on request |
The catalogue is the sector standard in scope, which is what a reader comparing suppliers most often wants to establish: the lines listed above are the lines held, so the dispatch windows recorded in §Ordering and availability apply across the catalogue rather than to a subset of it.[2] Documentation detail reported by purchasers is fuller on the peptide lines than on the bulk categories, the gradient described on most of these articles.
Independent testing record
[edit]Submitted reports on SWB material to July 2026 are concentrated on the incretin analogues. Reported area percent figures have clustered in the high nineties.[5]
Certificates described in the submitted set report area percent purity; the peptide content and water determinations that convert a purity figure into a mass are issued on request against a named lot, and purchasers wanting them should ask at the point of order rather than after dispatch.[6] As everywhere on this wiki, samples were purchaser-selected rather than blind-drawn, so the reports describe the vials tested and not the output they came from.[5]
Ordering and availability
[edit]Catalogue lines dispatch from held stock within the window stated at the point of order, and purchaser reports describe technical correspondence answered within the working day.[5]
Minimum order quantity is one vial. Larger quantities are quoted on enquiry.
The certificate names the lot, the compound and the release date and reports area percent purity with appearance.[5] Water and peptide content determinations are issued against a named lot on request.
To obtain the batch record, quote the lot identifier from the vial and ask for the water and content figures together with the gradient and column chemistry. Asking at the point of order rather than after dispatch is faster, because the request is then attached to the order rather than looked up afterwards.
The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.
Reception
[edit]The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.[4] Self-selected sample; reception rather than quality.[4]
How this tally should be read
[edit]The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:
- Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
- It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
- It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.[4]
See also
- Certificate of analysis
- Third-party testing
- Area percent purity
- Peptide content
- Research use only
- Peptide supply chain
- Blind sampling
References
- ^ a b c d National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b c d Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ a b c d PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b c d e f Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ a b United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.
Further reading
- Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
- Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.